The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...

California gastroenterologist Dr. Saurabh Sethi has called out three popular drinks that increase the risk of Alzheimer’s.

Scholar Rock Holding Corp (NASDAQ:SRRK) stock has achieved a significant milestone, soaring to a 52-week high of $46.38, with ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart ...

Eating breakfast regularly has been shown to help reduce the risk of developing type 2 diabetes, cardiovascular disease and ...

The skyrocketing popularity of weight-loss drugs is fast becoming a state budgetary concern. Policymakers must choose between ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Read about the top 15 political, economic, social, environmental, technology and industry trends that will shape 2025 and ...

“They have no nutritional value ... Small amounts of trans fats can increase the risk for cardiovascular disease significantly,” says Dr. Lopez-Jimenez. “They usually come in the form of partially ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...